Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vopr Virusol ; 44(2): 69-71, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10358900

RESUMO

Polydispersed aerosols from allantoic fluid of chick embryos induced with influenza virus with different median weight aerodynamic diameters of corpuscles (0.5, 0.8, 1.1, 2.2, and 6.0 mu are effectively deposited in respiratory organs of mice weighing 18-19 g. The sensitivity of mice of different weight to aerogenic infection with influenza virus (strain A/Aichi/2/68) was virtually the same. The efficacies of aerogenic 50% infective and lethal doses (1.8-2.5 lg) for mice of the same weight were different. The sensitivity of mice to aerogenic infection and of developing chicken embryos to the virus (ID50 = EID50) is the same. Mice weighing 10-19 g can be infected via airways with adapted influenza virus in studies of therapeutic and prophylactic effects of drugs.


Assuntos
Vírus da Influenza A/patogenicidade , Aerossóis , Animais , Embrião de Galinha , Exposição por Inalação , Camundongos , Sistema Respiratório/virologia
2.
Antibiot Khimioter ; 43(4): 20-3, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9606500

RESUMO

The time dependence of interferon production in blood, tissues of the respiratory tract, brain and olfactory tract of mice BALB/c was investigated after administration of the interferon inductor ridostin by various routes. Intraperitoneal injection of ridostin in a dose of 5 mg/kg induced intensive accumulation of interferon in the blood serum with the peak in 8 hours (2560 U/0.2 ml) while no interferon was detected in the tissues of the respiratory tract and brain of the animals. Intracerebral injection of ridostin in the same dose induced accumulation of interferon in both the tissues of the brain (maximum 160 U/0.2 ml in 24 hours) and the blood serum (maximum 1280 U/0.2 ml in 8 hours). After respiratory administration of ridostin interferon was detected only in the site of the administration in the tissues of the upper respiratory tract and lungs of the mice.


Assuntos
Indutores de Interferon/farmacologia , Interferons/biossíntese , RNA de Cadeia Dupla/farmacologia , RNA Fúngico/farmacologia , Administração por Inalação , Animais , Encéfalo/metabolismo , Relação Dose-Resposta a Droga , Injeções Intraperitoneais , Injeções Intraventriculares , Indutores de Interferon/administração & dosagem , Interferons/sangue , Interferons/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Condutos Olfatórios/metabolismo , RNA de Cadeia Dupla/administração & dosagem , RNA Fúngico/administração & dosagem , Sistema Respiratório/metabolismo
3.
Vestn Ross Akad Med Nauk ; (4): 17-20, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9633235

RESUMO

There are known 3 likely mechanisms of virus conveyance into the central nervous system (CNS). These include hematogenic penetration, spread along the peripheral nerves, and the olfactory pathway which begins from the infected olfactory neuroepithelial cells. The possibility of viral spread into CNS via the olfactory pathway was shown for the representatives of togaviruses, herpesviruses, coronaviruses, rhabdoviruses, and for some others. This study suggests that the olfactory pathway of viral conveyance into CNS may be blocked by specific mucosal antibodies in the nasal mucosa. The recombinant TK- variant of WR vaccinia strain with inserted genes coding structural and nonstructural proteins of TBE virus is accumulated in the branches of the respiratory tract only while the parenteral vaccinia strain is detected in the brain regions, spleen, respiratory tract, and in blood. The protective activity of recombinant strain and inactivated TBE vaccine after mice immunization by escarification or intranasally, or subcutaneously was comparatively studied. The findings indicate that intranasal immunization by recombinant strain is the most protective against intraperitoneal challenge by TBE virus. The mucosal and humoral immune response that was induced by intranasal immunization seems to provide the highest levels of protection, which was experimentally observed.


Assuntos
Encefalite Transmitida por Carrapatos/prevenção & controle , Vacinação , Vacinas Sintéticas/administração & dosagem , Vacinas Virais/administração & dosagem , Administração Intranasal , Animais , Encéfalo/virologia , Modelos Animais de Doenças , Encefalite Transmitida por Carrapatos/imunologia , Encefalite Transmitida por Carrapatos/virologia , Flavivirus/imunologia , Flavivirus/isolamento & purificação , Flavivirus/patogenicidade , Camundongos , Camundongos Endogâmicos BALB C , Vacinas Sintéticas/uso terapêutico , Vacinas Virais/uso terapêutico
4.
Vopr Virusol ; 42(5): 226-9, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9424849

RESUMO

Therapeutic and prophylactic effects of immunomodifiers ridostin, reaferon, and polyribonate used alone and in various combinations were assessed in experiments on guinea pigs infected with Venezuelan equine encephalomyelitis (VEE) (strain Trinidad), Marburg (strain Popp), and Ebola (M/C-8 variant of Zaire strain) viruses at doses 5 to 20 respiratory LD50 through the respiratory airways. Urgent prophylactic simultaneous intramuscular and intranasal administration of ridostin protected the animals infected with Marburg virus (p = 0.1) and prolonged their life span by 2.4 days (p = 0.15). In Ebola infection a combination of ridostin and reaferon appreciably prolonged the mean life span: by 2.9 days (p = 0.04). In VEE ridostin alone or in combination with reaferone appreciably increased the share of survivors; ridostin with reaferon and polyribonate notably prolonged the mean life span of infected animals. None of these drugs or combinations produced an appreciable therapeutic effect in any of the studied infections.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Encefalomielite Equina Venezuelana/tratamento farmacológico , Doença pelo Vírus Ebola/tratamento farmacológico , Doença do Vírus de Marburg/tratamento farmacológico , Animais , Células Cultivadas , Embrião de Galinha , Encefalomielite Equina Venezuelana/prevenção & controle , Cobaias , Doença pelo Vírus Ebola/prevenção & controle , Dose Letal Mediana , Doença do Vírus de Marburg/prevenção & controle
6.
Vopr Virusol ; 40(4): 158-61, 1995.
Artigo em Russo | MEDLINE | ID: mdl-7483565

RESUMO

Time course of Marburg virus (strain Popp) accumulation and changes in hematological parameters were studied in aerosol infected M.rhesus monkeys. The lungs were the first organ in which the virus was detected after respiratory infection of monkeys. Four days after inoculation the virus was detected in the liver, spleen, blood, and thymus. Six days after inoculation the virus was present in virtually all organs and secretions. The period of fever was associated with manifest leukopenia in primates. Blood clotting time drastically increased by the moment of animal death.


Assuntos
Microbiologia do Ar , Doença do Vírus de Marburg/transmissão , Marburgvirus/patogenicidade , Animais , Fígado/virologia , Pulmão/virologia , Macaca mulatta , Doença do Vírus de Marburg/patologia , Doença do Vírus de Marburg/virologia , Marburgvirus/isolamento & purificação , Baço/virologia , Timo/virologia , Viremia
7.
Antibiot Khimioter ; 40(5): 24-7, 1995 May.
Artigo em Russo | MEDLINE | ID: mdl-8534175

RESUMO

The study of the preventive and therapeutic action of some immunomodulators (ridostin, reaferon and polyribonate) used alone and in combinations was conducted on laboratory animals infected aerogenically by Marburg or Ebola virus. It was found that special preventive intranasal and intramuscular administration of ridostin provided protection of the animals infected by Marburg virus (p = 0.1) and an increase in their mean lifespan by 2.4 days (p = 0.15). In the Ebola infection combined administration of ridostin and reaferon caused an essential increase in the mean lifespan of the animals by 2.9 days (p = 0.04). None of the tested drugs had any significant positive effect when used in various combinations according to the treatment schemes in Marburg and Ebola infections in guinea pigs.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Doença pelo Vírus Ebola/tratamento farmacológico , Doença pelo Vírus Ebola/prevenção & controle , Doença do Vírus de Marburg/tratamento farmacológico , Doença do Vírus de Marburg/prevenção & controle , Aerossóis , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Cobaias , Doença pelo Vírus Ebola/mortalidade , Doença pelo Vírus Ebola/transmissão , Interferon Tipo I/uso terapêutico , Interferon alfa-2 , Interferon-alfa , Doença do Vírus de Marburg/mortalidade , Doença do Vírus de Marburg/transmissão , Compostos Orgânicos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Proteínas Recombinantes , Fatores de Tempo
8.
Antibiot Khimioter ; 40(5): 28-31, 1995 May.
Artigo em Russo | MEDLINE | ID: mdl-8534176

RESUMO

The investigation of the prevention and treatment action of some immunomodulators (ridostin, reaferon and polyribonate) used alone and in combinations was conducted on laboratory animals infected aerogenically by Venezuelan equine encephalitis (VEE) virus. A lower death rate of the aerogenically infected mice (10-30 respiratory LD50) was observed after intramuscular injection of ridostin. The preventive affect of ridostin and ridostin + reaferon administered intranasally and intramuscularly was achieved in the aerogenically infected guinea pigs (10 respiratory LD50). The results of the study on the early virus reproduction in the animals were used for the choice of the treatment scheme. The immunomodulators had no effect when the treatment was started 1 day after the VEE virus infection.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Encefalomielite Equina Venezuelana/tratamento farmacológico , Encefalomielite Equina Venezuelana/prevenção & controle , Aerossóis , Animais , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Encefalomielite Equina Venezuelana/mortalidade , Encefalomielite Equina Venezuelana/transmissão , Cobaias , Interferon Tipo I/uso terapêutico , Interferon alfa-2 , Interferon-alfa , Camundongos , Compostos Orgânicos , RNA de Cadeia Dupla/uso terapêutico , RNA Fúngico/uso terapêutico , Proteínas Recombinantes , Fatores de Tempo
9.
Vopr Virusol ; 40(3): 119-21, 1995.
Artigo em Russo | MEDLINE | ID: mdl-7676673

RESUMO

Marburg virus (strain Popp) was found to accumulate in various organs of guinea pigs after aerogenic infection. At the initial stage of the infection primary multiplication of the virus took place in the lungs. The presence of the virus in bronchopulmonary washings 2-3 days after infection, leukopenia and hyperthermia 4 days after infection are the earliest virological and clinical signs of disease in aerogenically infected guinea pigs.


Assuntos
Microbiologia do Ar , Líquido da Lavagem Broncoalveolar/virologia , Pulmão/virologia , Doença do Vírus de Marburg/fisiopatologia , Animais , Febre/fisiopatologia , Cobaias , Leucopenia/fisiopatologia , Linfonodos/virologia , Doença do Vírus de Marburg/transmissão , Doença do Vírus de Marburg/virologia , Marburgvirus/fisiologia , Replicação Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...